GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PepperLime Health Acquisition Corp (NAS:PEPL) » Definitions » ROE %

PepperLime Health Acquisition (PepperLime Health Acquisition) ROE % : -16.94% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PepperLime Health Acquisition ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. PepperLime Health Acquisition's annualized net income for the quarter that ended in Sep. 2023 was $-0.83 Mil. PepperLime Health Acquisition's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was $4.91 Mil. Therefore, PepperLime Health Acquisition's annualized ROE % for the quarter that ended in Sep. 2023 was -16.94%.

The historical rank and industry rank for PepperLime Health Acquisition's ROE % or its related term are showing as below:

PEPL' s ROE % Range Over the Past 10 Years
Min: 0.65   Med: 0.65   Max: 1.15
Current: 1.15

During the past 2 years, PepperLime Health Acquisition's highest ROE % was 1.15%. The lowest was 0.65%. And the median was 0.65%.

PEPL's ROE % is not ranked
in the Diversified Financial Services industry.
Industry Median: 0.38 vs PEPL: 1.15

PepperLime Health Acquisition ROE % Historical Data

The historical data trend for PepperLime Health Acquisition's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PepperLime Health Acquisition ROE % Chart

PepperLime Health Acquisition Annual Data
Trend Dec21 Dec22
ROE %
- 0.65

PepperLime Health Acquisition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.28 2.21 -0.04 5.72 -16.94

Competitive Comparison of PepperLime Health Acquisition's ROE %

For the Shell Companies subindustry, PepperLime Health Acquisition's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PepperLime Health Acquisition's ROE % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, PepperLime Health Acquisition's ROE % distribution charts can be found below:

* The bar in red indicates where PepperLime Health Acquisition's ROE % falls into.



PepperLime Health Acquisition ROE % Calculation

PepperLime Health Acquisition's annualized ROE % for the fiscal year that ended in Dec. 2022 is calculated as

ROE %=Net Income (A: Dec. 2022 )/( (Total Stockholders Equity (A: Dec. 2021 )+Total Stockholders Equity (A: Dec. 2022 ))/ count )
=1.088/( (167.657+168.744)/ 2 )
=1.088/168.2005
=0.65 %

PepperLime Health Acquisition's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=-0.832/( (7.331+2.494)/ 2 )
=-0.832/4.9125
=-16.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.


PepperLime Health Acquisition  (NAS:PEPL) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-0.832/4.9125
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.832 / 0)*(0 / 11.493)*(11.493 / 4.9125)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*2.3395
=ROA %*Equity Multiplier
=N/A %*2.3395
=-16.94 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-0.832/4.9125
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-0.832 / -0.832) * (-0.832 / -1.424) * (-1.424 / 0) * (0 / 11.493) * (11.493 / 4.9125)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 0.5843 * N/A % * 0 * 2.3395
=-16.94 %

Note: The net income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


PepperLime Health Acquisition ROE % Related Terms

Thank you for viewing the detailed overview of PepperLime Health Acquisition's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


PepperLime Health Acquisition (PepperLime Health Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
548 Market Street, Suite 97425, San Francisco, CA, USA, 94104
PepperLime Health Acquisition Corp is a blank check company.
Executives
Kepos Capital Lp 10 percent owner 11 TIMES SQUARE, 35TH FLOOR, NEW YORK NY 10036
Shaolin Capital Management Llc 10 percent owner 230 NW 24TH STREET, SUITE 603, MIAMI FL 33127
Ramzi Haidamus director, officer: Chief Executive Officer C/O IMMERSION CORPORATION, 50 RIO ROBLES, SAN JOSE CA 95134
Eran Pilovsky officer: Chief Financial Officer
Pepperone Llc 10 percent owner 548 MARKET STREET, PMB 97425, SAN FRANCISCO CA 94104
Michelle Fang director 548 MARKET STREET, SUITE 97425, SAN FRANCISCO CA 94104
Britney Blair director 548 MARKET STREET, SUITE 97425, SAN FRANCISCO CA 94104
Frank Ferrari director, officer: President 548 MARKET STREET, SUITE 97425, SAN FRANCISCO CA 94104
Op De Beek Maurice officer: Executive Vice President 548 MARKET STREET, SUITE 97425, SAN FRANCISCO CA 94104

PepperLime Health Acquisition (PepperLime Health Acquisition) Headlines